Alpana Joshi, MS, OTR/L | |
200 1st St Sw, Rochester, MN 55905 | |
(507) 284-2511 | |
Not Available |
Full Name | Alpana Joshi |
---|---|
Gender | Female |
Speciality | Occupational Therapy |
Experience | 22 Years |
Location | 200 1st St Sw, Rochester, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073912697 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 056.010127 (Illinois) | Secondary |
225X00000X | Occupational Therapist | 105768 (Minnesota) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mayo Clinic | 6507778255 | 4232 |
News Archive
A population-based study assesses seroprevalence in a representative sample of children from regions with high and low community transmission.
Options are limited in America's battle of the bulge. While diet and exercise can help in the short term, they are frustratingly ineffective in the long run.
The income gap between the rich and poor in the United States has reached its highest levels since the Great Depression. Given past evidence that a wider rich-poor gap can be harmful to a population's health, tax policies that widen or narrow this gap may influence the overall health of a society.
Two discoveries at UC Santa Barbara point to potential new drug therapies for patients with kidney disease. The findings are published in this week's issue of the Proceedings of the National Academy of Sciences.
StockPreacher.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 5 days ago
Provider Name | Mayo Clinic |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
A population-based study assesses seroprevalence in a representative sample of children from regions with high and low community transmission.
Options are limited in America's battle of the bulge. While diet and exercise can help in the short term, they are frustratingly ineffective in the long run.
The income gap between the rich and poor in the United States has reached its highest levels since the Great Depression. Given past evidence that a wider rich-poor gap can be harmful to a population's health, tax policies that widen or narrow this gap may influence the overall health of a society.
Two discoveries at UC Santa Barbara point to potential new drug therapies for patients with kidney disease. The findings are published in this week's issue of the Proceedings of the National Academy of Sciences.
StockPreacher.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Alpana Joshi, MS, OTR/L 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Alpana Joshi, MS, OTR/L 200 1st St Sw, Rochester, MN 55905 Ph: (507) 284-2511 |
News Archive
A population-based study assesses seroprevalence in a representative sample of children from regions with high and low community transmission.
Options are limited in America's battle of the bulge. While diet and exercise can help in the short term, they are frustratingly ineffective in the long run.
The income gap between the rich and poor in the United States has reached its highest levels since the Great Depression. Given past evidence that a wider rich-poor gap can be harmful to a population's health, tax policies that widen or narrow this gap may influence the overall health of a society.
Two discoveries at UC Santa Barbara point to potential new drug therapies for patients with kidney disease. The findings are published in this week's issue of the Proceedings of the National Academy of Sciences.
StockPreacher.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 5 days ago
Amy L Krekelberg, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Danielle Anshus, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Erika Hope Mckeever, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Deborah Engen, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Susan D Hansen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mary B Clark, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Sara Kathleen Tallman, O.T.D. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |